Topotecan (topoisomerase inhibitor), is capable of inhibiting HIF‐2α and HIF‐1α accumulation and also transcriptional activity, and thus inhibits VEGF expression in NB cells.184. The gene discussed is HIF1A; the disease is neuroblastoma.